There were 35 Y2H and 14 co-IP HspB2 binding partners associated with disease, and of these, 28 (57%) were associated with myopathies and neurodegenerative diseases such as Alzheimer’s disease (AD) (Fig 5C). Here, HSPB2 is linked to early-onset autosomal dominant Alzheimer disease.